US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phio Pharmaceuticals

2.96

+0.500020.33%

Post-market: 2.990.0300+1.01%19:52 EDT

Volume:2.07M

Turnover:6.11M

Market Cap:14.14M

PE:-0.31

High:3.19

Open:2.54

Low:2.53

Close:2.46

Loading ...

Overview Company News Filings

Phio Pharmaceuticals Announces Key Management Appointments: Robert Infarinato as VP of Strategic Development, Lisa Carson as VP of Finance and Administration

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle

Phio Pharmaceuticals: Undervalued Innovator with Promising siRNA Therapy and Strategic Growth Potential

BUZZ-U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker Barrel

Phio Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Phio Pharmaceuticals assumed with a Buy at H.C. Wainwright

Phio Pharmaceuticals Corp : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $14

THOMSON REUTERS

Robert J. Bitterman, Chairman, President & CEO, Acquires Common Shares of Phio Pharmaceuticals Corp

Director Robert L. Ferrara Reports Acquisition of Common Shares of Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp. to Participate in Sidoti Micro-Cap Virtual Investor Conference

Phio Pharma Q1 EPS $(0.47) Down From $(0.41) YoY

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Phio Pharmaceuticals Potential Skin Cancer Treatment Recommended for Dose Escalation

MT Newswires Live

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort

Phio Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894

Phio Pharmaceuticals Corp reports results for the quarter ended December 31 - Earnings Summary

Phio Pharmaceuticals Corp expected to post a loss of $1.23 a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PHIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":2.96,"timestamp":1749240000000,"preClose":2.46,"halted":0,"volume":2072725,"hourTrading":{"tag":"盘后","latestPrice":2.99,"preClose":2.96,"latestTime":"19:52 EDT","volume":13098,"amount":38787.3965,"timestamp":1749253955459},"delay":0,"floatShares":4765135,"shares":4778154,"eps":-9.405447,"marketStatus":"Market Closed","change":0.5,"latestTime":"06-06 16:00:00 EDT","open":2.54,"high":3.19,"low":2.5343,"amount":6107704.975675,"amplitude":0.266545,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.405447,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.46,"preHourTrading":{"tag":"盘前","latestPrice":2.59,"preClose":2.46,"latestTime":"09:26 EDT","volume":66896,"amount":176531.4931616,"timestamp":1749216418636},"postHourTrading":{"tag":"盘后","latestPrice":2.99,"preClose":2.96,"latestTime":"19:52 EDT","volume":13098,"amount":38787.3965,"timestamp":1749253955459},"volumeRatio":1.3785496876950738,"impliedVol":2.2675,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","floatShares":4765135,"roa":"-43.43%","roe":"-76.12%","lyrEps":-9.079757,"volumeRatio":1.3785496876950738,"shares":4778154,"dividePrice":0,"high":3.19,"amplitude":0.266545,"preClose":2.46,"low":2.5343,"week52Low":0.9657,"pbRate":"1.16","week52High":9.79,"institutionHeld":0,"latestPrice":2.96,"eps":-9.405447,"divideRate":0,"volume":2072725,"delay":0,"ttmEps":-9.405447,"open":2.54,"prevYearClose":1.8,"prevWeekClose":2,"prevMonthClose":2,"prevQuarterClose":1.3,"fiveDayClose":2,"twentyDayClose":1.8,"sixtyDayClose":1.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541836852","title":"Phio Pharmaceuticals Announces Key Management Appointments: Robert Infarinato as VP of Strategic Development, Lisa Carson as VP of Finance and Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2541836852","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541836852?lang=en_us&edition=fundamental","pubTime":"2025-06-06 19:46","pubTimestamp":1749210388,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Announces Key Management Appointments: Robert Infarinato as VP of Strategic Development, Lisa Carson as VP of Finance and Administration. Phio Pharmaceuticals Corp. has announced key management changes as part of a strategic initiative to enhance awareness of its INTASYL siRNA portfolio. Robert Infarinato has been appointed as Vice President of Strategic Development, transitioning from his previous role as Chief Financial Officer. Lisa Carson has been named Vice President of Finance and Administration, joining Phio with over 20 years of finance and accounting leadership experience. These changes aim to focus on expanding the potential applications of the INTASYL gene silencing technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDLyZ5jv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2541704350","title":"BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle","url":"https://stock-news.laohu8.com/highlight/detail?id=2541704350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541704350?lang=en_us&edition=fundamental","pubTime":"2025-06-06 02:03","pubTimestamp":1749146604,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, CircleEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL6N3S80F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","COUR","BPMC","CHWY","TSYW.SI","LU1235294995.USD","UDMY","FIVE","FERG","NEM","LU2362541273.HKD","LU0077335932.USD","FCX","PHIO","LU0198837287.USD","LTH","LU0724618789.USD","LU0476273544.USD","REGN","CBUS","LU2237443895.HKD","TRUMP.USD.CC","WEC","CDE","IE00BK4W5M84.HKD","IE00BLSP4452.SGD","LU0912757837.SGD","PVH","CRCL","LU0354030438.USD","BV","HL","CHPT","BW","SO","SCCO","TXN","LU2237438978.USD","AVGO","CBRL","IE00B7SZLL34.SGD","LU0345780521.USD","LU2413666426.HKD","RGNX","OMI","DLTR","LU0345780950.USD"],"gpt_icon":1},{"id":"2541190077","title":"Phio Pharmaceuticals: Undervalued Innovator with Promising siRNA Therapy and Strategic Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2541190077","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541190077?lang=en_us&edition=fundamental","pubTime":"2025-06-06 00:45","pubTimestamp":1749141920,"startTime":"0","endTime":"0","summary":"Matthew Keller, an analyst from H.C. Wainwright, has initiated a new Buy rating on Phio Pharmaceuticals (PHIO). Matthew Keller’s rating is based on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/phio-pharmaceuticals-undervalued-innovator-with-promising-sirna-therapy-and-strategic-growth-potential-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/phio-pharmaceuticals-undervalued-innovator-with-promising-sirna-therapy-and-strategic-growth-potential-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2541707395","title":"BUZZ-U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker Barrel","url":"https://stock-news.laohu8.com/highlight/detail?id=2541707395","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541707395?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:08","pubTimestamp":1749128939,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker BarrelEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL6N3S80F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0050427557.USD","BHP.AU","NEM","BK4216","IE00B29SXL02.USD","SO","LU1721427968.SGD","PL","FIVE","BK4585","BK4208","BV","RIO.UK","IE00B7SZLL34.SGD","BK4122","BK4505","IE00B19Z9P08.USD","LU0075056555.USD","AU","FERG","LU0055631609.USD","LU2347655156.SGD","LU2384288077.EUR","UDMY","BW","LTH","SCCO","LU0456854461.SGD","BK4202","HL","BK4096","CHPT","BK4139","COUR","LU0898667661.SGD","LU2500361329.USD","WEC","CBUS","CDE","PHIO","BK4123","CHWY","RGNX","RIO.AU","BK4532","FCX","IE00BMG7P926.USD","PVH","CBRL","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2541022438","title":"Phio Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2541022438","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541022438?lang=en_us&edition=fundamental","pubTime":"2025-06-05 19:20","pubTimestamp":1749122400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 07:20 ET (11:20 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2541219890","title":"Phio Pharmaceuticals assumed with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2541219890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541219890?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:15","pubTimestamp":1749118509,"startTime":"0","endTime":"0","summary":"H.C. Wainwright assumed coverage of Phio Pharmaceuticals (PHIO) with a Buy rating and $14 price target Phio’s lead asset is PH-762 is an siRNA-base...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-assumed-with-a-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-assumed-with-a-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2541702902","title":"Phio Pharmaceuticals Corp : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2541702902","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541702902?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:09","pubTimestamp":1749118141,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S801U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2537131921","title":"Robert J. Bitterman, Chairman, President & CEO, Acquires Common Shares of Phio Pharmaceuticals Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2537131921","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537131921?lang=en_us&edition=fundamental","pubTime":"2025-05-23 21:04","pubTimestamp":1748005480,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President & CEO of Phio Pharmaceuticals Corp., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL76RbC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2537322959","title":"Director Robert L. Ferrara Reports Acquisition of Common Shares of Phio Pharmaceuticals Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2537322959","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537322959?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:13","pubTimestamp":1747858438,"startTime":"0","endTime":"0","summary":"Robert L. Ferrara, a Director at Phio Pharmaceuticals Corp., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL4fCnbd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2536686053","title":"Phio Pharmaceuticals Corp. to Participate in Sidoti Micro-Cap Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2536686053","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536686053?lang=en_us&edition=fundamental","pubTime":"2025-05-19 19:46","pubTimestamp":1747655163,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. will participate in the Sidoti Micro-Cap Virtual Investor Conference on May 21-22, 2025. CEO and Chairman Robert Bitterman will present an update on the company's INTASYL siRNA technology and progress on the clinical trial with their lead compound PH-762 for treating skin cancers. The presentation is scheduled for 10:00 AM ET on May 22, and one-on-one investor meetings will be held on both days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile  on May 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL1Z9MsQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2535036308","title":"Phio Pharma Q1 EPS $(0.47) Down From $(0.41) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535036308","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535036308?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:46","pubTimestamp":1747341970,"startTime":"0","endTime":"0","summary":"Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.47) per share. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45454305/phio-pharma-q1-eps-0-47-down-from-0-41-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0},{"id":"2532867070","title":"Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2532867070","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532867070?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:45","pubTimestamp":1746099900,"startTime":"0","endTime":"0","summary":"Registration Link for Presentation and live Q&A to take place, Wednesday, May 7, 2025 at 2:00 pm EST. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update on the company's proprietary INTASYL siRNA technology and progress on the on-going clinical trial with lead compound PH-762 for treatment of skin cancers.\"All stakeholders, investors, and other individual followers are invited to join this event to learn more about Phio Pharmaceuticals and our continuing pursuit of innovative pathways towards a cancer free future using our Intasyl technology,\" stated Robert Bitterman, CEO and Chairman of Phio Pharmaceuticals.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-participation-renmark-114500932.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-participation-renmark-114500932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","MNQmain","TQQQ","NQmain","USJW.SI","QID","NVIW.SI","TSYW.SI",".IXIC","PSQ","QLD","USAW.SI","PHIO","BK4139"],"gpt_icon":1},{"id":"2526511532","title":"PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2526511532","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526511532?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:53","pubTimestamp":1744296780,"startTime":"0","endTime":"0","summary":"Shares of Phio Pharmaceuticals PHIO rallied 52.5% on Wednesday after the company announced that the Safety Monitoring Committee  has recommended dose escalation in an early-stage study of the company’s investigational skin cancer candidate, PH-762.PH-762 is Phio Pharmaceuticals’ lead and only clinical-stage candidate, which is being developed leveraging its proprietary IntasylsiRNA gene silencing technology to eliminate cancer. The phase Ib dose escalation study is evaluating the safety and tolerability of neoadjuvant use of intratumoral PH-762 for cutaneous squamous cell carcinoma, melanoma or Merkel cell carcinoma.The SMC’s decision allowing escalation to the next dose concentration was based on the favorable safety profile of the drug observed in the third cohort of the phase Ib study, which enrolled three patients with cutaneous squamous cell carcinoma. In these patients, injections were well tolerated, with no serious adverse events or dose-limiting toxicities. Pathology results a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-stock-soars-safety-panel-145300505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMC","BK4139","BK4007","DVAX","ADMA","PHIO","BK4144","BAYRY"],"gpt_icon":0},{"id":"2526539428","title":"Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2526539428","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526539428?lang=en_us&edition=fundamental","pubTime":"2025-04-10 00:06","pubTimestamp":1744214792,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/04/44717350/crude-oil-down-4-neogen-shares-plunge-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAW.SI","LU0823414478.USD","LU2357125470.USD","LU2211817866.USD","BE","USJW.SI","TSYW.SI","BK4075","LU1642822529.SGD","BK4198","BK4082","LU2506951792.HKD","VINC","LU1815336760.USD","XXII","QLD","SQQQ","LU0476273544.USD","BK4541","VERO","BK4585","LU0444973449.USD","NQmain","BK4588","PSQ","PHIO","NVIW.SI","LU0957808578.USD","NEOG","LU2249611893.SGD","BK4212",".IXIC","LU0444971666.USD","SMPL","MNQmain","LU0823414551.USD","TQQQ","BK4139","BK4182","QID","LU2294711713.HKD"],"gpt_icon":1},{"id":"2526365606","title":"Phio Pharmaceuticals Potential Skin Cancer Treatment Recommended for Dose Escalation","url":"https://stock-news.laohu8.com/highlight/detail?id=2526365606","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526365606?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:23","pubTimestamp":1744201406,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals  said Wednesday the Safety Monitoring Committee has recommended dose escalation in its phase 1b clinical trial of PH-762 as a potential neoadjuvant treatment for cutaneous squamous cell carcinoma, melanoma or Merkel cell carcinoma.The recommendation came after seven patients in the study with cutaneous carcinoma showed at least 90% tumor clearance after 36 days, the company said.Shares of the biotech firm were up more than 20% in recent premarket activity Wednesday.Price: 1.22, Change: +0.21, Percent Change: +20.76","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2526887363","title":"Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2526887363","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526887363?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:45","pubTimestamp":1744199100,"startTime":"0","endTime":"0","summary":"-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in third cohort, permitting escalation in next dose concentration. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL siRNA gene silencing technology to eliminate cancer. Phio announced today that the Safety Monitoring Committee  recommended dose escalation in Phio's Phase 1b clinical trial  for Phio's lead product candidate, PH-762.Phio's Phase 1b clinical trial is a multi-center, dose-escalating trial designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma. This trial assesses the tumor response and determines the recommended dose for further study of PH-762. In the third cohort of this trial, three patients with cutaneous squamous cell carcinoma were enrolled. For these patients, inj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-positive-safety-114500926.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-positive-safety-114500926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4580","LU0208291251.USD","LU0320765489.SGD","LU0417517546.SGD","BK4585","BK4139","LU0211331839.USD","LU1989772923.USD","PH","LU0256863811.USD","LU1989772840.SGD","PHIO","BK4144","BK4588","SMC","LU0256863902.USD","LU0070302665.USD","BK4161"],"gpt_icon":0},{"id":"2525896512","title":"Phio Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896512","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896512?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:51","pubTimestamp":1744113060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2025 07:51 ET (11:51 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0},{"id":"2524256808","title":"Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894","url":"https://stock-news.laohu8.com/highlight/detail?id=2524256808","media":"Newsfile","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524256808?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:45","pubTimestamp":1743680700,"startTime":"0","endTime":"0","summary":"To be presented at 11th Annual Immunotherapy of Cancer  Conference in Munich, Germany. Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp.  is a clinical-stage siRNA biotechnology company developing therapeutics using its proprietary INTASYL gene silencing technology to eliminate cancer. Phio today announced that podium presentations will be given on its two lead INTASYL product candidates, PH-762 and PH-894.The ITOC conference provides a unique platform for the exchange of latest findings in immunotherapy of cancer to advance oncology drug development and delivery.Melissa Maxwell, Phio's Director of Research and Program Management, was awarded two speaker presentations, as follows:. Plenary Session 3: New Targets and New Leads Date and Time: April 3, 2025, 16.30 - 16.45 PM . This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-Looking statements can be identified by words such as \"intends,\" \"be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-podium-presentations-114500937.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/phio-pharmaceuticals-announces-podium-presentations-114500937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU0256863811.USD","BK4585","LU1989772923.USD","BK4580","PH","PHIO","LU0320765489.SGD","LU0070302665.USD","LU0256863902.USD","BK4588","LU0208291251.USD","LU0211331839.USD","BK4161","LU1989772840.SGD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2524216942","title":"Phio Pharmaceuticals Corp reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524216942","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524216942?lang=en_us&edition=fundamental","pubTime":"2025-04-01 17:07","pubTimestamp":1743498428,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp reports results for the quarter ended December 31 - Earnings SummaryPhio Pharmaceuticals Corp PHIO.OQ reported a quarterly adjusted loss of 85 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL5N3QF0I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0},{"id":"2523355376","title":"Phio Pharmaceuticals Corp  expected to post a loss of $1.23 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2523355376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523355376?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:58","pubTimestamp":1743195485,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp  expected to post a loss of $1.23 a share - Earnings Preview Phio Pharmaceuticals Corp PHIO.OQ PHIO.O is expected to report resultson March 31 (estimated) for the period endi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB1U0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"PHIO","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2025-03-31","symbol":"PHIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"PHIO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-1.54},{"market":"US","date":"2024-08-14","symbol":"PHIO","fiscalQuarterEnding":"2024/06","expectedEps":-4.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-3.62},{"market":"US","date":"2024-07-05","symbol":"PHIO","defaultRemindTime":1720186200000,"type":"split","dateTimestamp":1720152000000,"forFactor":9,"toFactor":1,"ratio":9}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740024000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHIO","date":"2025-06-06","current":-1.73751,"percent":0.18633,"low":-5.606854,"twenty":-1.666289,"median":-0.776231,"eighty":-0.326887,"high":-0.115258,"avg":-1.122336,"sd":1.024019,"marketCap":11754258},"quantilePoints":[{"date":"2020-06-12","current":-1.242966,"twenty":-1.643898,"median":-1.180341,"eighty":-0.754259,"marketCap":11360705},{"date":"2020-06-19","current":-1.17781,"twenty":-1.638027,"median":-1.179806,"eighty":-0.754259,"marketCap":10765184},{"date":"2020-06-26","current":-1.167786,"twenty":-1.629606,"median":-1.179633,"eighty":-0.754259,"marketCap":10673566},{"date":"2020-07-02","current":-1.102631,"twenty":-1.623004,"median":-1.177076,"eighty":-0.754259,"marketCap":10078045},{"date":"2020-07-10","current":-1.448218,"twenty":-1.615926,"median":-1.170071,"eighty":-0.754259,"marketCap":13236708},{"date":"2020-07-17","current":-1.517783,"twenty":-1.603672,"median":-1.170071,"eighty":-0.754259,"marketCap":13872533},{"date":"2020-07-24","current":-1.562051,"twenty":-1.592438,"median":-1.170071,"eighty":-0.754259,"marketCap":14277148},{"date":"2020-07-31","current":-1.568375,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":14334950},{"date":"2020-08-07","current":-1.732802,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":15837809},{"date":"2020-08-14","current":-1.593726,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":13988137},{"date":"2020-08-21","current":-1.613483,"twenty":-1.588641,"median":-1.170071,"eighty":-0.754259,"marketCap":14161544},{"date":"2020-08-28","current":-1.574051,"twenty":-1.581024,"median":-1.170071,"eighty":-0.754259,"marketCap":13815448},{"date":"2020-09-04","current":-1.343542,"twenty":-1.573962,"median":-1.170071,"eighty":-0.754259,"marketCap":11792265},{"date":"2020-09-11","current":-1.284268,"twenty":-1.568071,"median":-1.170071,"eighty":-0.754259,"marketCap":11272018},{"date":"2020-09-18","current":-1.699185,"twenty":-1.561012,"median":-1.170071,"eighty":-0.754259,"marketCap":14913747},{"date":"2020-09-25","current":-1.455503,"twenty":-1.549285,"median":-1.170071,"eighty":-0.754259,"marketCap":12774954},{"date":"2020-10-02","current":-1.455503,"twenty":-1.541964,"median":-1.170071,"eighty":-0.754259,"marketCap":12774954},{"date":"2020-10-09","current":-1.468675,"twenty":-1.529717,"median":-1.170071,"eighty":-0.754259,"marketCap":12890564},{"date":"2020-10-16","current":-1.39623,"twenty":-1.521006,"median":-1.170071,"eighty":-0.754259,"marketCap":12254707},{"date":"2020-10-23","current":-1.39623,"twenty":-1.513652,"median":-1.170071,"eighty":-0.754259,"marketCap":12254707},{"date":"2020-10-30","current":-1.369885,"twenty":-1.508404,"median":-1.170071,"eighty":-0.754259,"marketCap":12023485},{"date":"2020-11-06","current":-1.468675,"twenty":-1.505641,"median":-1.170071,"eighty":-0.754259,"marketCap":12890564},{"date":"2020-11-13","current":-1.427145,"twenty":-1.503553,"median":-1.170071,"eighty":-0.754259,"marketCap":12832892},{"date":"2020-11-20","current":-1.414288,"twenty":-1.499895,"median":-1.170071,"eighty":-0.754259,"marketCap":12717280},{"date":"2020-11-27","current":-1.478574,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":13295339},{"date":"2020-12-04","current":-1.536431,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":13815591},{"date":"2020-12-11","current":-1.819289,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":16359047},{"date":"2020-12-18","current":-1.671432,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":15029513},{"date":"2020-12-24","current":-1.735717,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":15607571},{"date":"2020-12-31","current":-1.729289,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":15549765},{"date":"2021-01-08","current":-1.954289,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":17572969},{"date":"2021-01-15","current":-1.870718,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":16821494},{"date":"2021-01-22","current":-1.857861,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":16705882},{"date":"2021-01-29","current":-3.551126,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":31931721},{"date":"2021-02-05","current":-3.755344,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":33768050},{"date":"2021-02-12","current":-3.891489,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":34992269},{"date":"2021-02-19","current":-5.385349,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":48425057},{"date":"2021-02-26","current":-3.959408,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":35602998},{"date":"2021-03-05","current":-3.502553,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31494960},{"date":"2021-03-12","current":-4.360887,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":39213092},{"date":"2021-03-19","current":-4.180913,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37594774},{"date":"2021-03-26","current":-4.323942,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":38024743},{"date":"2021-04-01","current":-4.231616,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":37212827},{"date":"2021-04-09","current":-4.216228,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37077508},{"date":"2021-04-16","current":-3.523782,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":30988135},{"date":"2021-04-23","current":-3.585332,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31529413},{"date":"2021-04-30","current":-3.5552,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31264430},{"date":"2021-05-07","current":-4.109257,"twenty":-1.498848,"median":-1.169531,"eighty":-0.754151,"marketCap":36136808},{"date":"2021-05-14","current":-2.624434,"twenty":-1.499955,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-05-21","current":-2.926725,"twenty":-1.501287,"median":-1.169531,"eighty":-0.754151,"marketCap":28828240},{"date":"2021-05-28","current":-3.050389,"twenty":-1.503829,"median":-1.169531,"eighty":-0.754151,"marketCap":30046334},{"date":"2021-06-04","current":-2.844282,"twenty":-1.504533,"median":-1.169531,"eighty":-0.754151,"marketCap":28016176},{"date":"2021-06-11","current":-3.036649,"twenty":-1.506728,"median":-1.169531,"eighty":-0.754151,"marketCap":29910991},{"date":"2021-06-18","current":-3.022908,"twenty":-1.511311,"median":-1.169531,"eighty":-0.754151,"marketCap":29775647},{"date":"2021-06-25","current":-3.325199,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":32753212},{"date":"2021-07-02","current":-2.967946,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":29234272},{"date":"2021-07-09","current":-2.858022,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":28151520},{"date":"2021-07-16","current":-2.50077,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24632580},{"date":"2021-07-23","current":-2.583213,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25444644},{"date":"2021-07-30","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-06","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-13","current":-2.142581,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":23279142},{"date":"2021-08-20","current":-2.10521,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":22873111},{"date":"2021-08-27","current":-2.379261,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-09-03","current":-2.528744,"twenty":-1.513652,"median":-1.169531,"eighty":-0.754151,"marketCap":27474801},{"date":"2021-09-10","current":-2.553658,"twenty":-1.517656,"median":-1.169531,"eighty":-0.754151,"marketCap":27745489},{"date":"2021-09-17","current":-2.840165,"twenty":-1.535231,"median":-1.169531,"eighty":-0.754151,"marketCap":30858397},{"date":"2021-09-24","current":-2.678226,"twenty":-1.55235,"median":-1.169531,"eighty":-0.754151,"marketCap":29098928},{"date":"2021-10-01","current":-2.478916,"twenty":-1.568375,"median":-1.169531,"eighty":-0.754151,"marketCap":26933426},{"date":"2021-10-08","current":-2.279606,"twenty":-1.575639,"median":-1.177333,"eighty":-0.754151,"marketCap":24767924},{"date":"2021-10-15","current":-2.080297,"twenty":-1.592553,"median":-1.179943,"eighty":-0.754151,"marketCap":22602423},{"date":"2021-10-22","current":-2.030469,"twenty":-1.605485,"median":-1.187834,"eighty":-0.757627,"marketCap":22061047},{"date":"2021-10-29","current":-2.092754,"twenty":-1.626655,"median":-1.191091,"eighty":-0.757651,"marketCap":22737767},{"date":"2021-11-05","current":-2.130124,"twenty":-1.639611,"median":-1.196448,"eighty":-0.757891,"marketCap":23143798},{"date":"2021-11-12","current":-1.727879,"twenty":-1.652657,"median":-1.202967,"eighty":-0.759558,"marketCap":21249455},{"date":"2021-11-19","current":-1.507767,"twenty":-1.654895,"median":-1.210405,"eighty":-0.760343,"marketCap":18542518},{"date":"2021-11-26","current":-1.529778,"twenty":-1.652657,"median":-1.212029,"eighty":-0.760343,"marketCap":18813211},{"date":"2021-12-03","current":-1.298661,"twenty":-1.652657,"median":-1.2135,"eighty":-0.760343,"marketCap":15970928},{"date":"2021-12-10","current":-1.353689,"twenty":-1.652657,"median":-1.217439,"eighty":-0.760343,"marketCap":16647662},{"date":"2021-12-17","current":-1.287655,"twenty":-1.652657,"median":-1.227086,"eighty":-0.761524,"marketCap":15835581},{"date":"2021-12-23","current":-1.298661,"twenty":-1.652657,"median":-1.228561,"eighty":-0.763642,"marketCap":15970928},{"date":"2021-12-31","current":-1.10056,"twenty":-1.652657,"median":-1.228561,"eighty":-0.77102,"marketCap":13534684},{"date":"2022-01-07","current":-1.063471,"twenty":-1.652486,"median":-1.228561,"eighty":-0.771783,"marketCap":13078565},{"date":"2022-01-14","current":-0.973005,"twenty":-1.652486,"median":-1.228561,"eighty":-0.773446,"marketCap":11966015},{"date":"2022-01-21","current":-0.946812,"twenty":-1.652486,"median":-1.228561,"eighty":-0.776821,"marketCap":11643889},{"date":"2022-01-28","current":-0.871643,"twenty":-1.652486,"median":-1.228561,"eighty":-0.781639,"marketCap":10719469},{"date":"2022-02-04","current":-0.985881,"twenty":-1.652486,"median":-1.228561,"eighty":-0.784351,"marketCap":12124370},{"date":"2022-02-11","current":-0.986432,"twenty":-1.652316,"median":-1.228561,"eighty":-0.78546,"marketCap":12131138},{"date":"2022-02-18","current":-0.917427,"twenty":-1.652316,"median":-1.228561,"eighty":-0.790609,"marketCap":11282513},{"date":"2022-02-25","current":-0.928542,"twenty":-1.652316,"median":-1.228561,"eighty":-0.794492,"marketCap":11419214},{"date":"2022-03-04","current":-0.891013,"twenty":-1.652316,"median":-1.228561,"eighty":-0.797055,"marketCap":10957680},{"date":"2022-03-11","current":-0.847211,"twenty":-1.652316,"median":-1.228561,"eighty":-0.798197,"marketCap":10419000},{"date":"2022-03-18","current":-0.934375,"twenty":-1.652316,"median":-1.228561,"eighty":-0.802126,"marketCap":11490947},{"date":"2022-03-25","current":-0.921076,"twenty":-1.652316,"median":-1.228561,"eighty":-0.806184,"marketCap":12238333},{"date":"2022-04-01","current":-0.890312,"twenty":-1.646585,"median":-1.228151,"eighty":-0.808371,"marketCap":11829577},{"date":"2022-04-08","current":-2.39386,"twenty":-1.639396,"median":-1.224535,"eighty":-0.808371,"marketCap":31807215},{"date":"2022-04-14","current":-1.21221,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":16106631},{"date":"2022-04-22","current":-1.283516,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":17054081},{"date":"2022-04-29","current":-0.855881,"twenty":-1.639396,"median":-1.214647,"eighty":-0.808371,"marketCap":11372094},{"date":"2022-05-06","current":-0.870346,"twenty":-1.639396,"median":-1.212174,"eighty":-0.808371,"marketCap":11564291},{"date":"2022-05-13","current":-0.771725,"twenty":-1.639396,"median":-1.212137,"eighty":-0.803488,"marketCap":9663542},{"date":"2022-05-20","current":-0.723513,"twenty":-1.639396,"median":-1.206863,"eighty":-0.801113,"marketCap":9059827},{"date":"2022-05-27","current":-0.796268,"twenty":-1.639396,"median":-1.201104,"eighty":-0.797537,"marketCap":9970863},{"date":"2022-06-03","current":-0.839026,"twenty":-1.639396,"median":-1.198734,"eighty":-0.797167,"marketCap":10506284},{"date":"2022-06-10","current":-0.780888,"twenty":-1.639396,"median":-1.193559,"eighty":-0.796536,"marketCap":9778275},{"date":"2022-06-17","current":-0.729621,"twenty":-1.639396,"median":-1.184786,"eighty":-0.793918,"marketCap":9136315},{"date":"2022-06-24","current":-0.740965,"twenty":-1.639504,"median":-1.17781,"eighty":-0.790818,"marketCap":9278366},{"date":"2022-07-01","current":-0.767253,"twenty":-1.639504,"median":-1.17061,"eighty":-0.788511,"marketCap":9607541},{"date":"2022-07-08","current":-0.801831,"twenty":-1.639504,"median":-1.167786,"eighty":-0.787642,"marketCap":10040522},{"date":"2022-07-15","current":-0.771399,"twenty":-1.639504,"median":-1.158325,"eighty":-0.786964,"marketCap":9659458},{"date":"2022-07-22","current":-0.784051,"twenty":-1.639504,"median":-1.151485,"eighty":-0.78508,"marketCap":9817885},{"date":"2022-07-29","current":-0.780015,"twenty":-1.639504,"median":-1.145238,"eighty":-0.783179,"marketCap":9767348},{"date":"2022-08-05","current":-0.785578,"twenty":-1.639504,"median":-1.142726,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-12","current":-0.817469,"twenty":-1.639504,"median":-1.133577,"eighty":-0.781191,"marketCap":10108816},{"date":"2022-08-19","current":-0.795488,"twenty":-1.639504,"median":-1.124069,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-26","current":-0.763346,"twenty":-1.639504,"median":-1.118863,"eighty":-0.778622,"marketCap":9439539},{"date":"2022-09-02","current":-0.760806,"twenty":-1.639504,"median":-1.112659,"eighty":-0.776493,"marketCap":9408124},{"date":"2022-09-09","current":-0.793831,"twenty":-1.639504,"median":-1.110534,"eighty":-0.775608,"marketCap":9816519},{"date":"2022-09-16","current":-0.751086,"twenty":-1.639504,"median":-1.101669,"eighty":-0.77548,"marketCap":9287927},{"date":"2022-09-23","current":-0.678959,"twenty":-1.639504,"median":-1.09706,"eighty":-0.773926,"marketCap":8396012},{"date":"2022-09-30","current":-0.631022,"twenty":-1.639504,"median":-1.091535,"eighty":-0.773184,"marketCap":7803224},{"date":"2022-10-07","current":-0.613019,"twenty":-1.639504,"median":-1.084943,"eighty":-0.772177,"marketCap":7580587},{"date":"2022-10-14","current":-0.61578,"twenty":-1.639504,"median":-1.078622,"eighty":-0.771783,"marketCap":7614734},{"date":"2022-10-21","current":-0.641847,"twenty":-1.639504,"median":-1.066994,"eighty":-0.771127,"marketCap":7937079},{"date":"2022-10-28","current":-0.646376,"twenty":-1.639504,"median":-1.055575,"eighty":-0.767034,"marketCap":7993080},{"date":"2022-11-04","current":-0.619646,"twenty":-1.639504,"median":-1.037137,"eighty":-0.763737,"marketCap":7662539},{"date":"2022-11-11","current":-0.53798,"twenty":-1.639504,"median":-1.032527,"eighty":-0.7629,"marketCap":6563358},{"date":"2022-11-18","current":-0.44813,"twenty":-1.639504,"median":-1.023521,"eighty":-0.761465,"marketCap":5467186},{"date":"2022-11-25","current":-0.45362,"twenty":-1.639504,"median":-1.020329,"eighty":-0.759288,"marketCap":5534159},{"date":"2022-12-02","current":-0.445105,"twenty":-1.631759,"median":-1.011325,"eighty":-0.755853,"marketCap":5430283},{"date":"2022-12-09","current":-0.439027,"twenty":-1.631759,"median":-0.999192,"eighty":-0.753074,"marketCap":5356134},{"date":"2022-12-16","current":-0.426844,"twenty":-1.631759,"median":-0.992495,"eighty":-0.75098,"marketCap":5207495},{"date":"2022-12-23","current":-0.401525,"twenty":-1.631759,"median":-0.985881,"eighty":-0.747725,"marketCap":4898599},{"date":"2022-12-30","current":-0.416761,"twenty":-1.631759,"median":-0.979938,"eighty":-0.745379,"marketCap":5084483},{"date":"2023-01-06","current":-0.683398,"twenty":-1.631759,"median":-0.977213,"eighty":-0.742198,"marketCap":8337460},{"date":"2023-01-13","current":-0.60363,"twenty":-1.631759,"median":-0.977213,"eighty":-0.740355,"marketCap":7364287},{"date":"2023-01-20","current":-0.592652,"twenty":-1.631759,"median":-0.977213,"eighty":-0.737547,"marketCap":7230355},{"date":"2023-01-27","current":-0.581635,"twenty":-1.631759,"median":-0.977213,"eighty":-0.734106,"marketCap":7095951},{"date":"2023-02-03","current":-0.616179,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":7517380},{"date":"2023-02-10","current":-0.515331,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6287035},{"date":"2023-02-17","current":-0.489209,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5968344},{"date":"2023-02-24","current":-0.480806,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5865834},{"date":"2023-03-03","current":-0.560162,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6833982},{"date":"2023-03-10","current":-0.516031,"twenty":-1.631759,"median":-0.977213,"eighty":-0.728426,"marketCap":6295578},{"date":"2023-03-17","current":-0.535889,"twenty":-1.631759,"median":-0.977068,"eighty":-0.726171,"marketCap":6537842},{"date":"2023-03-24","current":-0.572334,"twenty":-1.631759,"median":-0.977068,"eighty":-0.71795,"marketCap":6570398},{"date":"2023-03-31","current":-0.563264,"twenty":-1.629249,"median":-0.975604,"eighty":-0.717167,"marketCap":6466270},{"date":"2023-04-06","current":-0.5793,"twenty":-1.629249,"median":-0.975604,"eighty":-0.714469,"marketCap":6650363},{"date":"2023-04-14","current":-0.505134,"twenty":-1.631759,"median":-0.973005,"eighty":-0.711472,"marketCap":5798933},{"date":"2023-04-21","current":-0.539966,"twenty":-1.631759,"median":-0.973005,"eighty":-0.704091,"marketCap":6198807},{"date":"2023-04-28","current":-0.423323,"twenty":-1.631759,"median":-0.973005,"eighty":-0.701367,"marketCap":4859744},{"date":"2023-05-05","current":-0.509822,"twenty":-1.631759,"median":-0.973005,"eighty":-0.697146,"marketCap":5852757},{"date":"2023-05-12","current":-0.510477,"twenty":-1.631759,"median":-0.9686,"eighty":-0.690766,"marketCap":5860280},{"date":"2023-05-19","current":-0.610776,"twenty":-1.631759,"median":-0.967994,"eighty":-0.681773,"marketCap":7598053},{"date":"2023-05-26","current":-0.454756,"twenty":-1.631759,"median":-0.965521,"eighty":-0.67868,"marketCap":5657164},{"date":"2023-06-02","current":-0.408797,"twenty":-1.631759,"median":-0.96266,"eighty":-0.676522,"marketCap":5085429},{"date":"2023-06-09","current":-0.431758,"twenty":-1.631759,"median":-0.958147,"eighty":-0.664276,"marketCap":5371071},{"date":"2023-06-16","current":-0.456909,"twenty":-1.631759,"median":-0.954712,"eighty":-0.657282,"marketCap":5683949},{"date":"2023-06-23","current":-0.419183,"twenty":-1.634269,"median":-0.944146,"eighty":-0.654729,"marketCap":5214633},{"date":"2023-06-30","current":-0.392634,"twenty":-1.636779,"median":-0.938527,"eighty":-0.648646,"marketCap":4884372},{"date":"2023-07-07","current":-0.419183,"twenty":-1.636779,"median":-0.938527,"eighty":-0.644655,"marketCap":5214633},{"date":"2023-07-14","current":-0.38984,"twenty":-1.636779,"median":-0.937013,"eighty":-0.639638,"marketCap":4849608},{"date":"2023-07-21","current":-0.370977,"twenty":-1.636779,"median":-0.937013,"eighty":-0.633655,"marketCap":4614950},{"date":"2023-07-28","current":-0.375867,"twenty":-1.636779,"median":-0.937013,"eighty":-0.631022,"marketCap":4675787},{"date":"2023-08-04","current":-0.353511,"twenty":-1.639289,"median":-0.93777,"eighty":-0.629587,"marketCap":4397673},{"date":"2023-08-11","current":-0.318579,"twenty":-1.639289,"median":-0.93777,"eighty":-0.624064,"marketCap":3963121},{"date":"2023-08-18","current":-0.406633,"twenty":-1.639289,"median":-0.93777,"eighty":-0.621893,"marketCap":5065831},{"date":"2023-08-25","current":-0.413767,"twenty":-1.639289,"median":-0.93777,"eighty":-0.619457,"marketCap":5154705},{"date":"2023-09-01","current":-0.379881,"twenty":-1.639289,"median":-0.93777,"eighty":-0.610776,"marketCap":4732553},{"date":"2023-09-08","current":-0.401282,"twenty":-1.639396,"median":-0.938527,"eighty":-0.608865,"marketCap":4999176},{"date":"2023-09-15","current":-0.311217,"twenty":-1.639504,"median":-0.939799,"eighty":-0.604931,"marketCap":3877138},{"date":"2023-09-22","current":-0.249687,"twenty":-1.639504,"median":-0.939799,"eighty":-0.602435,"marketCap":3110598},{"date":"2023-09-29","current":-0.262171,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3266128},{"date":"2023-10-06","current":-0.260388,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3243909},{"date":"2023-10-13","current":-0.313892,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3910466},{"date":"2023-10-20","current":-0.244336,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3043942},{"date":"2023-10-27","current":-0.226502,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2821757},{"date":"2023-11-03","current":-0.222578,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2772876},{"date":"2023-11-10","current":-0.181915,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2266293},{"date":"2023-11-17","current":-0.205332,"twenty":-1.639826,"median":-0.942079,"eighty":-0.597918,"marketCap":2394578},{"date":"2023-11-24","current":-0.196951,"twenty":-1.639826,"median":-0.942079,"eighty":-0.591142,"marketCap":2296840},{"date":"2023-12-01","current":-0.229112,"twenty":-1.639826,"median":-0.942079,"eighty":-0.581635,"marketCap":2671909},{"date":"2023-12-08","current":-0.19276,"twenty":-1.639719,"median":-0.941575,"eighty":-0.578835,"marketCap":2247971},{"date":"2023-12-15","current":-0.155046,"twenty":-1.639719,"median":-0.941575,"eighty":-0.573898,"marketCap":1808150},{"date":"2023-12-22","current":-0.16106,"twenty":-1.639719,"median":-0.941575,"eighty":-0.569388,"marketCap":1878277},{"date":"2023-12-29","current":-0.160075,"twenty":-1.639826,"median":-0.942079,"eighty":-0.563264,"marketCap":1866793},{"date":"2024-01-05","current":-0.159656,"twenty":-1.640714,"median":-0.944146,"eighty":-0.559038,"marketCap":1861906},{"date":"2024-01-12","current":-0.146644,"twenty":-1.640714,"median":-0.944146,"eighty":-0.544651,"marketCap":1710168},{"date":"2024-01-19","current":-0.138285,"twenty":-1.641601,"median":-0.946213,"eighty":-0.539172,"marketCap":1612675},{"date":"2024-01-26","current":-0.125713,"twenty":-1.640714,"median":-0.944146,"eighty":-0.534718,"marketCap":1466068},{"date":"2024-02-02","current":-0.127599,"twenty":-1.640714,"median":-0.944146,"eighty":-0.52585,"marketCap":1488059},{"date":"2024-02-09","current":-0.127348,"twenty":-1.640714,"median":-0.944146,"eighty":-0.522459,"marketCap":1485127},{"date":"2024-02-16","current":-0.136189,"twenty":-1.640714,"median":-0.944146,"eighty":-0.51385,"marketCap":1588240},{"date":"2024-02-23","current":-0.178077,"twenty":-1.640714,"median":-0.944146,"eighty":-0.512362,"marketCap":2076736},{"date":"2024-03-01","current":-0.226284,"twenty":-1.639826,"median":-0.942079,"eighty":-0.508511,"marketCap":2638922},{"date":"2024-03-08","current":-0.184798,"twenty":-1.639826,"median":-0.942079,"eighty":-0.503269,"marketCap":2155120},{"date":"2024-03-15","current":-0.197244,"twenty":-1.639826,"median":-0.935928,"eighty":-0.492183,"marketCap":2300261},{"date":"2024-03-22","current":-0.175999,"twenty":-1.639826,"median":-0.928542,"eighty":-0.488621,"marketCap":2052495},{"date":"2024-03-28","current":-0.152134,"twenty":-1.639826,"median":-0.921076,"eighty":-0.486408,"marketCap":1774186},{"date":"2024-04-05","current":-0.156456,"twenty":-1.640714,"median":-0.916562,"eighty":-0.480806,"marketCap":1693797},{"date":"2024-04-12","current":-0.296683,"twenty":-1.640714,"median":-0.91096,"eighty":-0.469768,"marketCap":3211894},{"date":"2024-04-19","current":-0.270514,"twenty":-1.640714,"median":-0.906077,"eighty":-0.458759,"marketCap":2928586},{"date":"2024-04-26","current":-0.29944,"twenty":-1.639826,"median":-0.902569,"eighty":-0.45362,"marketCap":3241740},{"date":"2024-05-03","current":-0.329002,"twenty":-1.639826,"median":-0.896424,"eighty":-0.44813,"marketCap":3561781},{"date":"2024-05-10","current":-0.326585,"twenty":-1.639826,"median":-0.890312,"eighty":-0.445105,"marketCap":3535609},{"date":"2024-05-17","current":-0.358601,"twenty":-1.639826,"median":-0.880558,"eighty":-0.440142,"marketCap":3362961},{"date":"2024-05-24","current":-0.375934,"twenty":-1.639826,"median":-0.869368,"eighty":-0.436591,"marketCap":3525507},{"date":"2024-05-31","current":-0.368247,"twenty":-1.639826,"median":-0.863934,"eighty":-0.431758,"marketCap":3453417},{"date":"2024-06-07","current":-0.367218,"twenty":-1.639826,"median":-0.848175,"eighty":-0.425948,"marketCap":3443775},{"date":"2024-06-14","current":-0.357426,"twenty":-1.640714,"median":-0.843753,"eighty":-0.421762,"marketCap":3351941},{"date":"2024-06-21","current":-0.349053,"twenty":-1.641601,"median":-0.832901,"eighty":-0.419183,"marketCap":3273422},{"date":"2024-06-28","current":-0.337449,"twenty":-1.644264,"median":-0.825843,"eighty":-0.417785,"marketCap":3164595},{"date":"2024-07-05","current":-0.284373,"twenty":-1.644264,"median":-0.821822,"eighty":-0.414991,"marketCap":2666854},{"date":"2024-07-12","current":-0.317983,"twenty":-1.644264,"median":-0.816685,"eighty":-0.411983,"marketCap":2982048},{"date":"2024-07-15","current":-0.274733,"twenty":-1.644264,"median":-0.812746,"eighty":-0.410799,"marketCap":2576449},{"date":"2024-08-02","current":-0.161304,"twenty":-1.655347,"median":-0.803629,"eighty":-0.407754,"marketCap":1512707},{"date":"2024-08-09","current":-0.143079,"twenty":-1.655347,"median":-0.80079,"eighty":-0.40521,"marketCap":1341794},{"date":"2024-08-16","current":-0.151733,"twenty":-1.655347,"median":-0.798197,"eighty":-0.402675,"marketCap":1316285},{"date":"2024-08-23","current":-0.303609,"twenty":-1.655347,"median":-0.796603,"eighty":-0.395988,"marketCap":2633806},{"date":"2024-08-30","current":-0.261937,"twenty":-1.655347,"median":-0.793831,"eighty":-0.391029,"marketCap":2272303},{"date":"2024-09-06","current":-0.260945,"twenty":-1.655347,"median":-0.789855,"eighty":-0.385648,"marketCap":2263696},{"date":"2024-09-13","current":-0.287734,"twenty":-1.655347,"median":-0.786887,"eighty":-0.381456,"marketCap":2496090},{"date":"2024-09-20","current":-0.352226,"twenty":-1.655347,"median":-0.781191,"eighty":-0.37873,"marketCap":3055559},{"date":"2024-09-27","current":-0.35421,"twenty":-1.655347,"median":-0.779362,"eighty":-0.374682,"marketCap":3072773},{"date":"2024-10-04","current":-0.313531,"twenty":-1.655347,"median":-0.775543,"eighty":-0.372417,"marketCap":2719878},{"date":"2024-10-11","current":-0.253007,"twenty":-1.655347,"median":-0.773907,"eighty":-0.36763,"marketCap":2194838},{"date":"2024-10-18","current":-0.262929,"twenty":-1.655347,"median":-0.773508,"eighty":-0.363792,"marketCap":2280910},{"date":"2024-10-25","current":-0.293687,"twenty":-1.655347,"median":-0.773177,"eighty":-0.357426,"marketCap":2547734},{"date":"2024-10-31","current":-0.312538,"twenty":-1.655347,"median":-0.772052,"eighty":-0.353511,"marketCap":2711271},{"date":"2024-11-08","current":-0.32246,"twenty":-1.65613,"median":-0.770744,"eighty":-0.35155,"marketCap":2797343},{"date":"2024-11-15","current":-0.221257,"twenty":-1.65613,"median":-0.76436,"eighty":-0.347708,"marketCap":1919407},{"date":"2024-11-22","current":-0.29352,"twenty":-1.65613,"median":-0.76436,"eighty":-0.344977,"marketCap":2177624},{"date":"2024-11-29","current":-0.386871,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2870195},{"date":"2024-12-06","current":-0.385449,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2859643},{"date":"2024-12-13","current":-0.408362,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":3029639},{"date":"2024-12-20","current":-0.247484,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339311,"marketCap":1836081},{"date":"2024-12-27","current":-0.297265,"twenty":-1.65613,"median":-0.76436,"eighty":-0.337364,"marketCap":2205407},{"date":"2025-01-03","current":-0.270241,"twenty":-1.65613,"median":-0.763489,"eighty":-0.332534,"marketCap":2004916},{"date":"2025-01-10","current":-0.240372,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326962,"marketCap":1783320},{"date":"2025-01-17","current":-0.831105,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6165966},{"date":"2025-01-24","current":-0.881902,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6542829},{"date":"2025-01-31","current":-0.836676,"twenty":-1.656913,"median":-0.7613,"eighty":-0.326585,"marketCap":6207299},{"date":"2025-02-07","current":-0.931978,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326585,"marketCap":6914344},{"date":"2025-02-14","current":-0.821793,"twenty":-1.656913,"median":-0.763435,"eighty":-0.326962,"marketCap":6096884},{"date":"2025-02-21","current":-0.789656,"twenty":-1.656913,"median":-0.765835,"eighty":-0.326962,"marketCap":5858459},{"date":"2025-02-28","current":-0.920729,"twenty":-1.656913,"median":-0.768837,"eighty":-0.326962,"marketCap":6830892},{"date":"2025-03-07","current":-0.862782,"twenty":-1.657245,"median":-0.771897,"eighty":-0.326887,"marketCap":6400976},{"date":"2025-03-14","current":-0.856343,"twenty":-1.657245,"median":-0.773343,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-21","current":-0.856343,"twenty":-1.657245,"median":-0.775465,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-28","current":-0.843465,"twenty":-1.657245,"median":-0.777869,"eighty":-0.326887,"marketCap":6257670},{"date":"2025-04-04","current":-0.781666,"twenty":-1.657245,"median":-0.779906,"eighty":-0.326887,"marketCap":5588912},{"date":"2025-04-11","current":-1.102651,"twenty":-1.656913,"median":-0.776375,"eighty":-0.326962,"marketCap":7883954},{"date":"2025-04-17","current":-1.804338,"twenty":-1.658575,"median":-0.776375,"eighty":-0.326962,"marketCap":12901015},{"date":"2025-04-25","current":-1.490249,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":10655283},{"date":"2025-05-02","current":-1.263037,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9030711},{"date":"2025-05-09","current":-1.202892,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8600677},{"date":"2025-05-16","current":-1.189526,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8505114},{"date":"2025-05-23","current":-1.299601,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8791803},{"date":"2025-05-30","current":-1.440862,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9747434},{"date":"2025-06-06","current":-1.73751,"twenty":-1.666289,"median":-0.776231,"eighty":-0.326887,"marketCap":11754258}],"updateTime":1749296758404}}}